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Erythrocyte voltage-dependent calcium influx is reduced in uremic cells [2]. Parathyroid hormone (PTH) also could
hemodialyzed patients. be involved because it is known to increase Ca21 influx
Background. Uremia displays increased cytosolic free cal- into many cell types [6, 10–13].cium ([Ca21]i) in many different cell types, supporting the hy-
Several studies have reported increased total intracel-pothesis of an altered Ca21 transport modifying the functional
lular calcium concentrations and decreased Ca21 ATPaseactivity of calcium signaling pathway.
Methods. Thirty-five hemodialyzed patients and 20 age- activity in erythrocytes from uremic patients [14–18].
matched subjects were studied. Erythrocyte resting [Ca21]i and Moreover, Zidek et al and Lindner et al have shown the
Ca21 influx were measured by the fluorescent Ca21-sensitive existence of a circulating erythrocyte membrane Ca21dye fura-2.
ATPase inhibitor in patients with chronic renal failureResults. We found an increase of resting [Ca21]i in erythro-
[17, 19, 20]. In these studies, it was shown that this inhibi-cytes from uremic hemodialyzed patients compared with
matched healthy controls (103 6 2.5 nm, N 5 20, vs. 90 6 4, tor is not PTH. The increase of the cellular calcium
N 5 20, P , 0.01). Moreover, we found an altered voltage- content may contribute to the decreased erythrocyte sur-
dependent Ca21 influx showing a reduced transport rate (0.42 6 vival and deformability, which are associated with mor-0.03 nm/second vs. 0.74 6 0.08, P , 0.01). High levels of plasma
phologic changes (mainly echynocytosis and spherocyto-parathyroid hormone (PTH) were related to augmented Ca21
sis), described in uremia [14, 21].entry (r 5 0.511, P , 0.05), contributing to maintain a high
level of [Ca21]i. Hemodialysis had no effect on cell calcium Because the erythrocyte calcium content measured in
level and Ca21 influx indices. The therapy with Ca21 antagonists previous studies [14–18] is mostly bound to the mem-
did not modify the values of resting [Ca21]i or Ca21 influx brane, the measurements of intracellular free calcium,indices, but the correlation between PTH and influx indices
considered an essential cellular messenger, are of partic-was lost.
ular interest. In this study, we measured the cytosolicConclusions. In conclusion, we found evidence for an alter-
ation of erythrocyte Ca21 influx caused by uremic toxicity that free calcium concentration ([Ca21]i) in erythrocytes from
could be related to some organ disorders in uremia. The chronic uremic patients chronically treated by dialysis. More-
increase of cellular calcium may contribute to influx derange- over, we measured the erythrocyte Ca21 influx, modu-ment.
lated by cellular membrane potential, which we have
recently characterized in human erythrocytes [22]. Ca21
influx displayed a sigmoidal kinetic structure. An analysis
Uremia displays increased cytosolic calcium in many
of its time course by a logistic function allowed us to
different rat (brain synaptosomes, pancreatic islets, thy-
determine some distinctive indices: initial influx rate,
mocytes, and cardiac myocytes) and human (T cells, B
intracellular Ca21 concentrations at which maximal in-cells, platelets, and polymorphonuclear neutrophils) cell
flux started and ended, maximal influx rate, and plateau.types [1–9]. An explanation of this phenomenon could
Findings were compared with those of an age-matchedbe the decreased activity of membrane Ca21 ATPase in
control group. As the antihypertensive therapy with
Ca21-channel blockers could influence calcium cellular
metabolism [23, 24] and erythropoietin stimulates in vitroKey words: uremia, membrane potential, intracellular calcium, para-
thyroid hormone, influx derangement. a rise of [Ca21]i in human erythroid precursors by modu-
lating calcium channels [25, 26], we evaluated if the treat-Received for publication May 29, 1998
ment of patients with Ca21 antagonists or erythropoietinand in revised form February 2, 1999
Accepted for publication February 2, 1999 could influence results. Moreover, we considered other
elements that could affect uremic Ca21 influx: the shorter 1999 by the International Society of Nephrology
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Table 1. Selected clinical data and blood biochemicalerythrocyte half-life, the hemodialysis treatment, and the
parameters of uremic patients
effect of uremic plasma on normal erythrocytes. We also
Parameter Patients (N 5 35)evaluated the relationship between circulating PTH and
Time on hemodialysis months 30.264.8the calcium homeostasis parameters considered in pa-
Kt/Va 1.360.06tients.
Systolic blood pressure ,150 mm Hg 159.364.0
Diastolic blood pressure , 95 mm Hg 83.662.2
PTH 10–65 pg/ml 257.8642.5
METHODS Calcium 2.1–2.6 mmol/liter 2.260.02
Phosphorus 0.8–1.55 mmol/liter 1.660.07Patients
Sodium 135–148 mEq/liter 140.460.5
Potassium 3.5–5 mEq/liter 5.260.1Thirty-five hemodialysis patients (age 56 6 2.4 years,
Cholesterol 125–200 mg/dl 17467.624 males and 11 females) and 20 healthy age-matched
Mean erythrocyte volume 80–94 fl 91.361.3
subjects as controls (age 47 6 3.8 years, 8 males and 12 Hematocrit 42–50% 28.560.7
females) were studied. Table 1 provides the patients a Kt/V, therapy prescription index, where K is the dialyzer clearance, t is the
duration of dialysis, and V is the volume of body water in which urea is distributedclinical data and biochemical parameters. Twenty pa-
tients did not receive any type of Ca21 antagonists. Fif-
teen patients received the following dihydropyridine
Ca21 antagonists: nifedipine (40 to 60 mg/day, N 5 11),
For some experiments, old and young erythrocytesfelodipine (5 to 10 mg/day, N 5 1), lacidipine (4 mg/day,
were prepared according to Malachi et al: 6 ml of packedN 5 1), and amlodipine (10 mg/day, N 5 2). Among the
erythrocytes were centrifuged for 30 minutes at 27,00020 patients untreated with Ca21 antagonists, 12 received
g at 108C [27]. After removing the residual plasma anderythropoietin i.v./s.c. (mean dose 5000 U/week). None
buffy coat, 0.5 ml from the top (young cells) and 0.5 mlof the studied patients received vitamin D for at least
from the bottom (old cells) were removed and suspended12 weeks before the study. The causes of kidney failure
in 2 ml of their own plasma for a 30-minute recreationwere the following: 10 unknown etiology, 9 type 2 diabe-
before next measurements.tes, 7 type 1 diabetes, 3 adult polycystic renal disease, 1
chronic pyelonephritis, 3 membranous glomerulonephri-
Measurement of cytosolic free calcium concentrationtis, 1 IgA nephropathy, and 1 focal glomerulosclerosis.
in erythrocytesNone of the patients had microcytotic anemia. The
The measurement of [Ca21]i in intact erythrocytes waspatients were dialyzed with cuprophane, polymethyl-
carried out with the fluorescent Ca21-sensitive dye fura-2metacrylate, or polyacrilonitrile membranes three times
as previously described [22]. In brief, packed cells wereper week (4-hr sessions). Electrolyte dialysate composi-
diluted to 1% hematocrit with a HEPES-buffered salinetion was the following: Ca 1.5 mmol/liter, K 3 or 2 mmol/
(HBS; in mm): NaCl 123, KCl 5, MgCl2 1, CaCl2 1, glucoseliter, and Na 140 mmol/liter.
10, HEPES 25, pH 7.4, at 378C, 285 mOsm/liter. Erythro-Blood was collected from patients immediately before
cytes were loaded with 0.5 mm fura-2 AM by incubationthe beginning of the first week of dialysis. In 10 patients,
for 45 minutes under shaking at 378C. Erythrocytes wereit was also collected immediately after hemodialysis.
washed with HBS to eliminate fura-2 in excess. Packed
Biochemical analyses cells were suspended in HBS at 0.1% hematocrit and
were transferred into a quartz cuvette for the fluores-Serum-intact PTH was determined by chemilumines-
cence measurements with a luminescence spectrometercence assay with polyclonal antibodies (Nichols Institute
(Perkin Elmer LS50; Perkin-Elmer, Norwalk, CT, USA).Diagnostics, San Juan Capistrano, CA, USA). The bio-
All experiments were performed at 378C under a mag-chemical parameters (calcium, phosphorus, sodium, po-
netic stirrer. Data were analyzed by the Intracellulartassium, and cholesterol) were determined by auto-
Biochemistry application software package (ICBC) thatanalyzer (Itachi 747; Itachi, Tokyo, Japan). The mean
allows a fluorescence lecture every 0.9 seconds. [Ca21]ierythrocyte volume and hematocrit were measured by
was determined using the two-wavelength method de-STKS (Coulter Electronics, Hialeah, FL, USA).
scribed by Grynkiewicz, Poenie and Tsien, with the exci-
Preparation of erythrocytes tation at 340 nm (fluorescence wavelength of Ca21-bound
fura-2) and 380 nm (fluorescence wavelength of Ca21-Blood (2 ml) from healthy subjects and patients was
free fura-2), and emission at 510 nm [28]. [Ca21]i wascollected in tubes containing 1/10 volume of anticoagu-
calculated according to the equation given by Poenie etlant (2.73% citric acid, 4.48% trisodium citrate, and 2%
al, and calibration parameters were determined by inglucose). Cells were prepared immediately after blood
vitro calibration method according to David-Dufilho etsampling and were maintained at room temperature.
al [29, 30]. Under our experimental conditions, the ratioBlood was centrifuged, and plasma and buffy coat were
discarded by suction. of fluorescence measured at 340 and 380 nm when satu-
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rated with Ca21 (Rmax) was 8.016 6 0.088, whereas in the a mathematical model that is commonly used to describe
absence of Ca21 Rmin was 0.316 6 0.035 (N 5 15). The function curves of sigmoidal shape [32]. The logistic func-
Ca21 fura-2 kD is 224 nm [28]. To validate the calibration tion is characterized by an initial phase with a slow in-
method and to evaluate incomplete fura-2 intracellular crease, a central phase with a rapid increase, and finally,
de-esterification, an in vivo calibration also was per- a saturation phase in which a plateau is attained. Its
formed. The fura-2–loaded erythrocytes were suspended equation is as follows:
in HBS solution (0.1% Ht), and the fluorescence was
measured. After the signal stabilization (approximately F(t) 5
B
(1 1 ke2lt)
1 C (Eq. 1)
one min), 20% Triton X100 was added, and the Rmax was
recorded; then 10 mm EGTA was added, and the Rmin The unknown parameters B, C, k, and l were estimated
was recorded. In this condition, Rmax was 6.912 6 0.328, in each individual time course by fitting the logistic func-
and Rmin was 0.257 6 0.019 (N 5 15). The dynamic range tion to calcium concentration experimental data by
of intracellular fura-2 (Rmax/Rmin) was 30.433 6 3.626 for means of weighted nonlinear least squares [33]. Weights
in vitro calibration and 28.677 6 2.210 for in vivo calibra- were set to the inverse of the experimentally determined
tion (P 5 NS), indicating a negligible presence into eryth- variance of the measurement error. The fit of the logistic
rocytes of incomplete fura-2 de-esterified forms. function to [Ca21]i data was good.
The intra-assay and interassay variation coefficients The availability of a mathematical description of
of resting [Ca21]i calculated in erythrocytes from a same [Ca21]i time course allowed us to identify objectively the
donor were 2.7% (N 5 6) and 3.1% (N 5 7), respectively. most relevant features of influx into erythrocytes in each
individual experiment. In fact, the mass-balance equa-Measurement of Ca21 influx in erythrocytes
tion applied to the erythrocytes indicates that the in-
Ca21 influx was measured as previously described [22]. flux corresponds to the rate of change of [Ca21]i (that
In brief, erythrocytes 1% hematocrit were depleted of is, the slope of logistic function). We could thus deter-
ATP by incubation for one hour at 378C in a medium mine the indices such as initial and maximal influx rates
containing (in mm) NaCl 140, KCl 5, iodoacetate 1, ino- and the cut-in and cut-out times, that is, the times when
sine 10, pH 7.4 (medium A). After 15 minutes from the Ca21 influx increases and decreases most rapidly. The
starting of incubation, 0.5 mm fura-2 AM were added definition and the mathematical formulation of each ki-
to the medium (45 min of loading). Erythrocytes were netic index as a function of B, C, k, and l are reported
washed with the medium A to eliminate fura-2 AM in
in Table 2. Figure 1 elucidates the meaning of each index
excess, diluted to 0.1% hematocrit in medium A plus 2
by making reference to the fit to [Ca21]i data providedmm EGTA-Tris, pH 7.2, and transferred into a quartz
by the logistic function in a representative study.cuvette for the fluorescence measurements at 378C under
magnetic stirring. After the stabilization of the fluores- Effect of uremic plasma in vitro
cence signal (approximately one minute), 20 mm CaCl2 To evaluate the effect of uremic plasma on erythrocytewere added. The Ca-EGTA binding in the unbuffered
Ca21 influx, in vitro cross-experiments were performed.medium caused a membrane depolarization, which was
Washed and packed normal erythrocytes were preincu-caused by a decrease of external pH, whereas internal
bated for 90 minutes in a shaking water bath at 378CpH remained unchanged for the high buffering capacity
with normal or compatible uremic plasma. After preincu-of hemoglobin. The membrane potential, measured ac-
bation, erythrocytes were washed, and Ca21 influx wascording to the method of Macey, Adorante, and Orme
measured as previously described.changed from 212 mV at the end of ATP depletion to
0 mV at the beginning of Ca21 influx [31]. [Ca21]i was Statistical analysis
calculated for every point of fluorescence lecture (one
The data are expressed as mean 6 sem. Student’s t-testevery 0.9 seconds) as described before.
was used for comparisons between groups. CorrelationsThe interassay variation coefficient of the maximal
were tested by linear regression analysis. A level of P ,influx rate calculated in erythrocytes from a same donor
0.05 was considered significant.was 5.6% (N 5 6).
Analysis of Ca21 influx data with logistic function
RESULTS
Because in erythrocytes the visual identification of
Erythrocyte free Ca21 concentrationthe calcium concentration time course features is not a
Erythrocyte resting [Ca21]i measured by fura-2 inreliable and reproducible technique, we used a compu-
healthy subjects and patients is shown in Figure 2. Theterized method to obtain an objective characterization
resting [Ca21]i in patients was higher than in controlsof the Ca21 influx. The nonlinear relationship between
[Ca21]i and time was described using a logistic function, (103 6 2.5 nm, N 5 20, vs. 90 6 4 nm, N 5 20, P , 0.01).
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Table 2. Indices of Ca21 influx derived from the parameters of the logistic function
Index abbreviation Definition Mathematical formulationa Units
Cut-in time (tin) Time when the Ca21 influx increases most rapidly. second
tin 5
ln1 k2 1 √32
k
Cut-in concentration (Cin) Value of Ca21 concentration for t 5 tin. nmCin 5
B
(1 1 ke2ktin)
1 C
Cut-out time (tout) Time when the Ca21 influx decreases most rapidly. second
tout 5
ln1 k2 2 √32
k
Cut-out concentration (Cout) Value of Ca21 concentration for t 5 tout. nmCout 5
B
(1 1 ke2ktout)
1 C
Initial influx rate (IIR) Ca21 influx rate for t 5 tin/2. nm/second
IIR 5
Bkke2k(tin/2)
(1 1 ke2k(tin/2))2
Maximal influx rate (MIR) Ca21 influx rate for t 5 (tin 1 tout)/2. nm/second
MIR 5
Bkke2k(tin1tout)/2
(1 1 ke2k(tin1tout/2))2
Plateau (P) Value of Ca21 concentration at steady state. P 5 B 1 C nm
a Indices are expressed as functions of the four parameters of the logistic function: B,C,k,l (see Methods section). The cut-in and cut-out times mark the boundaries
of the central portion of the sigmoidal curve. The maximal influx rate is calculated in the middle of this region, that is t 5 (tin 1 tout)/2.
Fig. 1. Erythrocyte voltage-dependent Ca21
influx. This figure shows a representative
curve of Ca21 influx measured, as described
in the Methods section. The points are the
experimental data, and the line drawn is the
fitted logistic function. Cin is the cut-in concen-
tration, and Cout is the cut-out concentration.
The description of indices is reported in
Table 2.
No significant difference was found compared with and in untreated patients, it was 97 6 3.0 nm (N 5 8,
P 5 NS).patients treated with Ca21 antagonists (103 6 3.5 nm,
N 5 15, P , 0.01 vs. controls). Resting [Ca21]i of patients was not correlated with the
clinical parameters listed in Table 1.Erythropoietin therapy also did not influence [Ca21]i.
Its level in treated patients was 106 6 3.3 nm (N 5 12), Erythrocyte resting [Ca21]i measured in 10 patients
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Table 3. Comparison between healthy subjects (controls) and
hemodialysis patients untreated with Ca21-antagonists of Ca21
influx indices calculated by logistic function
Controls Patients Statistical
Index (N 5 20) (N 5 20) significance
Cut-in time seconds 533628.8 417 623.7 P,0.01
Cut-in concentration nm 17768.8 143 64.2 P,0.01
Cut-out time seconds 948646.1 829 656.3 NS
Cut-out concentration nm 425630.2 282 614.4 P,0.001
Initial influx rate
nm /second 0.10560.009 0.084 60.006 NS
Maximal influx rate
nm /second 0.74560.08 0.427 60.36 P,0.01
Plateau nm 515638.1 334 618.3 P,0.001
Fig. 2. Erythrocyte free Ca21 concentration. A comparison between
controls (group 1, N 5 20), uremic patients treated with Ca21 antagonists followed by a faster increase that leads to a plateau.(group 2, N 5 15), and untreated uremic patients (group 3, N 5 20).
Data analyzed with a logistic function allowed the identi-[Ca21]i was measured as indicated in the Methods section (*P , 0.01).
fication of some time course influx indices described in
Table 2. In Figure 3, the curves represent the mean of
measured Ca21 influx time courses in controls and in
uremic patients untreated with Ca21 antagonists. Values
of influx indices are reported in Table 3. The initial influx
rate was similar in the two groups. In uremic patients,
the maximal influx was slower; the cut-in concentration
and the cut-out concentration, that is, the [Ca21]i values
at which maximal influx starts and ends, were reduced.
Finally, the plateau value was reduced.
A comparison of influx indices between patients
treated with Ca21 antagonists or erythropoietin and un-
treated patients did not show any statistical difference
(data not shown).
Ca21 influx indices of patients were not correlated with
the clinical parameters listed in Table 1, with exception
of PTH, as shown later in this article.
In 10 patients, the Ca21 influx was measured before
and immediately after a hemodialysis session, and noFig. 3. Erythrocyte Ca21 influx. The mean of Ca21 influxes were mea-
sured as described in the Methods section in controls (N 5 20) and in change of indices was observed. No differences were
patients untreated with Ca21 antagonists (N 5 20). Cin is the cut-in found between Ca21 influx indices measured in normal
concentration, and Cout is the cut-out concentration. erythrocytes from healthy subjects preincubated in nor-
mal or compatible uremic plasma (N 5 6; data not
shown).
Relationship between parathyroid hormone andbefore and immediately after a hemodialysis session did
Ca21 influxnot show any statistical difference (before dialysis
100.6 6 1.5 nm; after dialysis 101 6 1.6 nm, P 5 NS). In the uremic patients, the mean serum intact PTH
No differences were found between [Ca21]i values was elevated as reported in Table 1.
measured in erythrocytes from healthy subjects preincu- No correlation was found between PTH values and
bated in normal or compatible uremic plasma (N 5 6; erythrocyte resting [Ca21]i in uremic subjects untreated
data not shown). with Ca21 antagonists and in both groups of patients
treated with Ca21 antagonists or erythropoietin (data not
Erythrocyte voltage-dependent Ca21 influx shown).
Ca21 influx measured in depolarizing conditions by Direct correlations were found between PTH values
fura-2 in ATP-depleted erythrocytes displays a sigmoidal and Ca21 influx indices in uremic subjects untreated with
kinetic, as shown in Figures 1 and 3. The Ca21 entry is Ca21 antagonists. PTH was correlated with initial influx
rate (r 5 0.571, P , 0.01), cut-in concentration (r 5characterized by three phases: a slow increase of [Ca21]i
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indices (N 5 6) and resting [Ca21]i (N 5 6) between
young and old erythrocytes (data not shown).
DISCUSSION
Uremia is a state in which a widespread increase of
intracellular calcium concentration is responsible for
many pathological manifestations. Our results showed
that [Ca21]i was also increased in erythrocytes and that
hemodialytic treatment did not affect erythrocyte cal-
cium level. In earlier reports, because calcium measure-
ments in erythrocytes were undertaken by atomic ab-
sorption spectrophotometry [14–18], the results showed
a large variability (the calcium content measured in
erythrocytes from uremic patients ranged from 4.27 6
1.02 to 30.6 6 6.8 mm [16, 17]) and represented the mea-
surement of total calcium content.
We evaluated the intracellular calcium level by the
Ca21-sensitive fluorescent dye fura-2, a method that is
highly sensitive [28–30] and directly quantifies intracellu-
lar free calcium, which acts as second messenger in many
signaling pathways. In controls, the [Ca21]i values were
similar to those already reported using the same experi-
mental method of determination [22, 30, 34, 35], and
higher than this reported by indirect measurements after
incorporation of benz-2 AM as intracellular Ca21 chela-
tor (26 nm) [36].
Besides the passive Ca21 influx, the presence of volt-
age-sensitive calcium channels in the erythrocyte mem-
brane has been firstly hypothesized by Varecka and Car-
afoli [37]. A voltage-activated increase in calcium influx
was measured by Halperin et al, and a voltage-depen-
dent, nonselective cation channel was identified using
the patch clamp technique [38, 39]. Moreover, Striessnig,
Zernig, and Glossman have characterized Ca21 antago-
Fig. 4. Relationship between serum parathyroid hormone (PTH) and nists binding sites on the human erythrocyte membrane
maximal influx rate. Each datum point represents one patient. (A) Data
[40]. We have previously measured and characterizedare of patients untreated with Ca21 antagonists (N 5 20; r 5 0.5; P ,
0.05). (B) Data are of patients treated with Ca21 antagonists (N 5 15; this type of calcium transport that displays a sigmoidal
r 5 0.33; P 5 NS). kinetic [22]. It is stimulated by membrane depolarization
and inhibited in vitro by dihydropyridine Ca21 antago-
nists in the micromolar range. The features of this trans-
port (level of membrane depolarization, low transport
rate, and low affinity for dihydropyridines) are different0.485, P , 0.05), maximal influx rate (r 5 0.511, P ,
from those of excitable cells L-type Ca21 channels, and0.05), cut-out concentration (r 5 0.531, P , 0.05), and
its physiological role is still unknown.plateau (r 5 0.528, P , 0.05). All of these correlations
The influx kinetic suggests a regulation of this trans-were maintained in patients treated with erythropoietin,
port by variations in the intracellular free calcium con-but were lost in patients receiving Ca21 antagonists treat-
centrations. In fact, the maximal influx starts and endsment (Fig. 4).
at characteristic [Ca21]i levels. However, an influence of
Ca21 influx of young and old erythrocytes cellular K1 changes on the Ca21 influx cannot be ex-
cluded. The shape of the influx kinetic and its plateauTo evaluate whether or not the alterations of cellular
may be due to the increase of K1 permeability inducedcalcium handling may be attributed to the shorter uremic
by the high cellular Ca21 level [41]. The consequent cellhalf-life, Ca21 influx and resting [Ca21]i were measured
in young and old normal erythrocytes. membrane hyperpolarization could inhibit the activity
of channels.The results did not show any differences of Ca21 influx
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In this report, we have applied a logistic function to other cellular types where it activates voltage-dependent
calcium channels [6, 11, 12]. This hormone-mediatedcalcium concentration time courses in order to identify
the cut-in concentration and the cut-out concentration Ca21 influx is blunted or prevented by Ca21 channel
blockers such as verapamil or nifedipine. Moreover, Ca21in erythrocytes from 20 normal subjects, as reported
in Table 3. These values were decreased in the uremic channel blockers were able to reverse some uremic mani-
festations after an administration to uremic patients [23,population studied, suggesting an alteration of Ca21 in-
flux regulation mechanism. As the initial Ca21 influx 24]. The relationship between PTH and erythrocyte Ca21
influx remains poorly understood. It is unknown if eryth-rate is unchanged, the reduction of cut-in concentration
produces a lowering of the time necessary to initiate the rocytes have membrane receptors for the hormone, al-
though they potentially have the cellular pathways tofast rise in [Ca21]i levels. The reduction of the cut-out
concentration produces consequently a lower [Ca21]i pla- respond to PTH. In vitro experiments suggest a direct
effect of PTH on erythrocyte Ca21 transport [10, 13,teau (the maximal intracellular calcium concentration
reached). 21, 27].
In conclusion, our results indicate an impairment ofIon transports in uremic cells and particularly in eryth-
rocytes were found to be reduced (Na,K-ATPase, Na-K Ca21 entry across voltage-modulated channels and an
cotransport, Ca21 ATPase, anion exchanger) or un- alteration of possible regulatory mechanisms of this
changed (Na-Li exchange) [14–18, 42–45]. According to transport by intracellular calcium ions in erythrocytes
this generalized ion transport lowering, we found a re- from hemodialyzed uremic patients. Serum PTH levels
duction in the maximal rate of Ca21 entry. The uremic were related to the principal influx indices. The impair-
Ca21 influx alterations do not seem to be caused by acute ment of this Ca21 transport system did not influence
effects of circulating uremic toxins, as shown by in vitro resting erythrocyte [Ca21]i, which was higher in uremics
cross experiments and by measurements done before compared with healthy subjects and did not correlate
and after hemodialysis. Moreover, the Ca21 influx seems with serum PTH levels. Therefore, we suggest that the
to be unaffected by the known different erythrocyte age alterations of the erythrocyte Ca21 influx may be consid-
distribution between normal and uremic subjects [27], ered to be a manifestation of uremic toxicity and could
because it was similar in young and old erythrocytes. be correlated to some organ disorders, especially those
The chronic increase of [Ca21]i in uremic erythrocytes linked to hyperparathyroidism.
could be a cause of the altered influx regulation and of
the reduction in the maximal influx rate observed. In ACKNOWLEDGMENTS
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